Opioid misuse and prescription drug diversion remain challenges in Europe, Australia and North America. To combat misuse, prescription monitoring programs (PMPs) have been implemented in many countries. However, PMP use remains an under studied topic, particularly with respect to PMP utilization. Many programs in the US allow delegate access, whereby a prescriber or pharmacist can delegate access to another staff member (e.g., medical assistant). One recent study found a cost savings with the use of delegates, instead of physicians. The objective of this study was to examine the number of PMP patient queries by provider type and assess the rates of delegate queries. A retrospective study using de-identified data from the Texas PMP was used to determine the mean number of patient queries by provider type (pharmacists and physicians) and the query rates among each respective delegate type (pharmacists’ delegate vs. physicians’ delegate). Data from 2017 to 2018 was used to assess trends in overall utilization and queries by provider type during the study period. The mean number of prescriber queries decreased from 113.5 in 2017 to 102.1 in 2018 (p=0.01). Pharmacists queries increased from 1,093,228 to 2,000,705 from 2017-2018 and the mean (M) number of pharmacists querying increased from 97.3 in 2017 to 158.3 in 2018 (p<.001). In 2018, the rate of queries among prescribers’ delegates was 2.89 per 1,000 (M=345) queries, while pharmacists’ delegates queried at a rate of 6.84 per 1,000 (M=146) queries. PMP patient queries have increased significantly over the past 2 years in Texas. Although, delegate access has increased, overall incorporation of delegates among pharmacists and prescribers remains relatively low. Considering the potential time and cost savings associated with delegate access to PMPs, more research is needed to determine cost savings, and increasing delegation, especially as many states move towards mandatory use.